Piecing Together an International CDMO
Iterative development is a fixture in manufacturing environments where ideas are conceived, needs and aspirations are reassessed in light of those ideas, and then advanced to something that, often, is…
Revitalized Microbial Systems Enable Development and Manufacturing of Innovative Biologics
Introduction Microbial production systems, such as Escherichia coli and yeast, are becoming more important than ever in manufacturing innovative biologics—including nanobodies, enzymes, cytokines, growth hormones, virus-like particles, and other complex…
The Greening of Biopharma
With governments and environmental organizations pushing industries to reduce their greenhouse gas emissions, biopharmaceutical companies around the world are finding ways to make their business more sustainable. They have signed…
The Global Capacity Squeeze in Biomanufacturing
The global capacity squeeze in the biomanufacturing sector is intensifying. While innovation in biologics continues apace, with an expanding portfolio of complex modalities, the available infrastructure has become increasingly limited,…